These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Bouzourene H, Bosman FT, Seelentag W, Matter M, Coucke P. Cancer; 2002 Feb 15; 94(4):1121-30. PubMed ID: 11920483 [Abstract] [Full Text] [Related]
6. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Kuo LJ, Liu MC, Jian JJ, Horng CF, Cheng TI, Chen CM, Fang WT, Chung YL. Ann Surg Oncol; 2007 Oct 15; 14(10):2766-72. PubMed ID: 17551794 [Abstract] [Full Text] [Related]
9. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients. Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L, Blondon J. Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):1062-73. PubMed ID: 15234040 [Abstract] [Full Text] [Related]
11. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D. Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):665-77. PubMed ID: 15708244 [Abstract] [Full Text] [Related]
12. Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer. Yeo SG, Kim DY, Kim TH, Jung KH, Hong YS, Chang HJ, Park JW, Lim SB, Choi HS, Jeong SY. Int J Radiat Oncol Biol Phys; 2010 Sep 01; 78(1):164-71. PubMed ID: 20004532 [Abstract] [Full Text] [Related]
15. Neoadjuvant therapy for rectal cancer down-stages the tumor but reduces lymph node harvest significantly. Wijesuriya RE, Deen KI, Hewavisenthi J, Balawardana J, Perera M. Surg Today; 2005 Sep 01; 35(6):442-5. PubMed ID: 15912290 [Abstract] [Full Text] [Related]
16. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Kim YS, Kim JH, Yoon SM, Choi EK, Ahn SD, Lee SW, Kim JC, Yu CS, Kim HC, Kim TW, Chang HM. Int J Radiat Oncol Biol Phys; 2009 Jul 01; 74(3):796-802. PubMed ID: 19289261 [Abstract] [Full Text] [Related]
17. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation. Díaz-González JA, Calvo FA, Cortés J, García-Sabrido JL, Gómez-Espí M, Del Valle E, Muñoz-Jiménez F, Alvarez E. Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1122-8. PubMed ID: 16406393 [Abstract] [Full Text] [Related]
18. Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer. Pucciarelli S, Capirci C, Emanuele U, Toppan P, Friso ML, Pennelli GM, Crepaldi G, Pasetto L, Nitti D, Lise M. Ann Surg Oncol; 2005 Feb 15; 12(2):111-6. PubMed ID: 15827790 [Abstract] [Full Text] [Related]
19. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Levy LB, Ellis LM, Crane CH. Am J Clin Oncol; 2006 Jun 15; 29(3):219-24. PubMed ID: 16755173 [Abstract] [Full Text] [Related]